It is equal to the share price times the number of * All numbers are in millions except for per share data and ratio.
Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.Zacks Investment Research is releasing its prediction for GERN based on the 1-3 month trading system that nearly triples the S&P 500.This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. It is the total market value to buy the whole company. GERN 1.83 0.01 (0.55%). * All numbers are in millions except for per share data and ratio. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. In depth view into GERN Market Cap explanation, calculation, historical data and more Market Cap. Only PremiumPlus Member can access this feature. Nasdaq-100 off less than 0.1% For companies with multiple common share classes, market capitalization includes both classes. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA. ]Geron to Present at the H.C. Wainwright Global Investment ConferenceStem Cell Therapy Market Is Expected To Reach USD 15.63 Billion By 2025 | Emerging Players - Anterogen Co. Ltd., Pharmicell Co. Ltd., Stemcell Technologies Inc.Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Antisense Oligonucleotides Market By Application, Growth, Analysis 2020-2025Geron Corporation Reports Second Quarter 2020 Financial Results and Current EventsGeron to Present at the BTIG Virtual Biotechnology ConferenceBiopharmaceutical Leader Robert J. Spiegel, MD, FACP Appointed to the Athenex Board of DirectorsGeron to Announce Second Quarter Financial Results on August 6, 2020Cord Blood Stem Cells Market 2020 Share, Size Growing Rapidly with Recent Trends, Development, Revenue, Demand and Forecast to 2026 Says MarketReportsWorld.comStem Cell Umbilical Cord Blood Market Insights, Forecast to 2020 Analysis by Application, Size, Production, Market Share, Consumption, Trends and Forecast 2026Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Geron Receives Positive Opinion from the EMA Committee for Orphan Medicinal Products for Orphan Drug Designation in the European Union for Imetelstat to Treat Myelodysplastic SyndromesGeron Receives Positive Opinion from the EMA Committee for Orphan Medicinal Products for Orphan Drug Designation in the European Union for Imetelstat to Treat Myelodysplastic SyndromesStem Cell Umbilical Cord Blood Market 2020 Global Overview, Latest Technologies, Business Strategy, Key Vendors, Segments, Demands, Growth Factors, Size, Share by Forecast to 2026Global Cord Blood Stem Cells Market 2020: Industry Size & Share, Business Strategies, Growth Analysis, Regional Demand, Revenue, Key Manufacturers and 2026 Forecast Research Report Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.Real time prices by BATS. Zacks Ranks stocks can, and often do, change throughout the month. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages.
The information on this site is in no way guaranteed for completeness, accuracy or in any other way. See rankings and related performance below.The scores are based on the trading styles of Value, Growth, and Momentum.
Here’s how top fund managers are positioning their portfolios ahead of the U.S. election Geron Corp. operates as a biotechnology company. The scores are based on the trading styles of Value, Growth, and Momentum. The real price you pay is the Enterprise Value.Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. ]Geron Corp (GERN) CEO John Scarlett on Q2 2020 Results - Earnings Call TranscriptGeron (GERN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA. Geron has a Market Cap of $633.15 Mil as of today(2020-07-16). Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. GON | Complete Geron Corp. stock news by MarketWatch.